As private markets explode and AI makes automation increasingly possible, Ilicheva saw an opportunity to build the next ...

While high-performing teams use AI more than others (78% versus 54%), their tech skills take a backseat to their ...

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...